A guide to better pharma demand research

Discover the three essential steps for optimizing the quality and reliability of demand research.

There are more drugs in development today than ever before. At the same time, drug development costs are rising while average revenues fall. Against this turbulent backdrop, pharma companies are challenged to maximise pipeline potential while limiting financial risk. 


Demand research is fundamental to meeting this unprecedented need for guidance. However, while demand studies are powerful tools that can help companies avoid large and costly mistakes, they also have the potential to produce misleading results.


In this paper, we outline three essential steps that market researchers and pharma companies can take to avoid this danger – and, instead, optimise the quality, reliability and longevity of their demand research results:

  • Step 1: Get market representation right.
  • Step 2: Understand and address share inflation.
  • Step 3: Look at the bigger picture.

Download the white paper

Download

More insights about Health

Related news

  • KEYS: Screen time
    Media Measurement Webinar

    [WEBINAR] KEYS: Screen time

    At our first KEYS webinar of the year we’ll be looking at what’s really happening on screens these days. What’s changing? What’s enduring? And how can businesses do better when it comes to engaging with people on their screens, in real time?
  • [Webinar] KEYS: What can we learn from what happened in 2025?
    Brand Image Webinar

    [Webinar] KEYS: What can we learn from what happened in 2025?

    In this final KEYS webinar of the year, we’ll be looking at the last 12 months through the rear-view mirror.
  • [Webinar] KEYS: THE MIDDLE CLASS: In Crisis?
    Society Webinar

    [Webinar] KEYS: THE MIDDLE CLASS: In Crisis?

    At our next KEYS webinar, we’ll be sharing on-the-ground perspectives as people give us their in-the-moment takes on how they see their lives - and their status in life - these days. Along the way we’ll hear about freedom (in the US), familismo (in Mexico) and understatedness (in the UK).